Skip to main content

Table 1 Demographic data on patients and healthy controls

From: Evaluation of antibodies against human HSP60 in patients with MPO-ANCA associated glomerulonephritis: a cohort study

 

AAV (N = 86)

MPO-ANCA (N = 42)

PR3-ANCA (N = 44)

HC (N = 69)

Age (years)*

62.2 ± 13.5

65.9 ± 10.9

59.7 ± 15.2

40.4 ± 9.8

Male gender (%)

69

64

73

59

  1. AAV, ANCA-associated vasculitis; MPO-ANCA, antineutrophil cytoplasmic antibodies against myeloperoxidase; PR3-ANCA, ANCA against proteinase 3; HC, healthy controls
  2. * Mean ± standard deviation
Back to article page

Journal of Autoimmune Diseases

ISSN: 1740-2557